Cite
HARVARD Citation
Kremer, J. et al. (n.d.). OP0028 POST-APPROVAL COMPARATIVE SAFETY STUDY OF TOFACITINIB AND BIOLOGIC DMARDS: FIVE–YEAR RESULTS FROM A US-BASED RHEUMATOID ARTHRITIS REGISTRY. Annals of the rheumatic diseases. pp. 82-83. [Online].